 | • レポートコード：QYR9NV00699 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、アミロイドーシス治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AG-10、ALN-ANG、ALN-TTRsc02、CAEL-101、カナキヌマブ、その他に、用途別には、ALアミロイドーシス、AAアミロイドーシス、ATTRアミロイドーシス、その他にセグメント区分し、アミロイドーシス治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・アミロイドーシス治療薬の世界市場概要 ・アミロイドーシス治療薬の製造コスト構成分析 ・アミロイドーシス治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・アミロイドーシス治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・アミロイドーシス治療薬のセグメント分析（種類別） （AG-10、ALN-ANG、ALN-TTRsc02、CAEL-101、カナキヌマブ、その他） ・アミロイドーシス治療薬のセグメント分析（用途別） （ALアミロイドーシス、AAアミロイドーシス、ATTRアミロイドーシス、その他） ・アミロイドーシス治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Pfizer Inc.、ProteoTech, Inc.、Alnylam Pharmaceuticals, Inc.、Arcturus Therapeutics, Inc、Bellus Health Inc.、Bsim2、Celgene Corporation、Millennium Pharmaceuticals, Inc.、Onyx Pharmaceuticals, Inc.、GlaxoSmithKline Plc、Isis Pharmaceuticals, Inc.、Prothena Corporation Plc、SOM Innovation Biotech SL、） ・アミロイドーシス治療薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Amyloidosis Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Amyloidosis Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amyloidosis Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Amyloidosis Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Amyloidosis Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer Inc.
ProteoTech, Inc.
Alnylam Pharmaceuticals, Inc.
Arcturus Therapeutics, Inc
Bellus Health Inc.
Bsim2
Celgene Corporation
Millennium Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Isis Pharmaceuticals, Inc.
Prothena Corporation Plc
SOM Innovation Biotech SL
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
AG-10
ALN-ANG
ALN-TTRsc02
CAEL-101
canakinumab
Others
Segment by Application
AL amyloidosis
AA amyloidoses
ATTR amyloidoses
Others
Table of Contents
Executive Summary
1 Industry Overview of Amyloidosis Therapeutics
1.1 Definition of Amyloidosis Therapeutics
1.2 Amyloidosis Therapeutics Segment by Type
1.2.1 Global Amyloidosis Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AG-10
1.2.3 ALN-ANG
1.2.4 ALN-TTRsc02
1.2.5 CAEL-101
1.2.6 canakinumab
1.2.7 Others
1.3 Amyloidosis Therapeutics Segment by Applications
1.3.1 Global Amyloidosis Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 AL amyloidosis
1.3.3 AA amyloidoses
1.3.4 ATTR amyloidoses
1.3.5 Others
1.4 Global Amyloidosis Therapeutics Overall Market
1.4.1 Global Amyloidosis Therapeutics Revenue (2014-2025)
1.4.2 Global Amyloidosis Therapeutics Production (2014-2025)
1.4.3 North America Amyloidosis Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Amyloidosis Therapeutics Status and Prospect (2014-2025)
1.4.5 China Amyloidosis Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Amyloidosis Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Amyloidosis Therapeutics Status and Prospect (2014-2025)
1.4.8 India Amyloidosis Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Amyloidosis Therapeutics
2.3 Manufacturing Process Analysis of Amyloidosis Therapeutics
2.4 Industry Chain Structure of Amyloidosis Therapeutics
3 Development and Manufacturing Plants Analysis of Amyloidosis Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Amyloidosis Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Amyloidosis Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Amyloidosis Therapeutics Production and Capacity Analysis
4.2 Amyloidosis Therapeutics Revenue Analysis
4.3 Amyloidosis Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Amyloidosis Therapeutics Regional Market Analysis
5.1 Amyloidosis Therapeutics Production by Regions
5.1.1 Global Amyloidosis Therapeutics Production by Regions
5.1.2 Global Amyloidosis Therapeutics Revenue by Regions
5.2 Amyloidosis Therapeutics Consumption by Regions
5.3 North America Amyloidosis Therapeutics Market Analysis
5.3.1 North America Amyloidosis Therapeutics Production
5.3.2 North America Amyloidosis Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Amyloidosis Therapeutics Import and Export
5.4 Europe Amyloidosis Therapeutics Market Analysis
5.4.1 Europe Amyloidosis Therapeutics Production
5.4.2 Europe Amyloidosis Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Amyloidosis Therapeutics Import and Export
5.5 China Amyloidosis Therapeutics Market Analysis
5.5.1 China Amyloidosis Therapeutics Production
5.5.2 China Amyloidosis Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Amyloidosis Therapeutics Import and Export
5.6 Japan Amyloidosis Therapeutics Market Analysis
5.6.1 Japan Amyloidosis Therapeutics Production
5.6.2 Japan Amyloidosis Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Amyloidosis Therapeutics Import and Export
5.7 Southeast Asia Amyloidosis Therapeutics Market Analysis
5.7.1 Southeast Asia Amyloidosis Therapeutics Production
5.7.2 Southeast Asia Amyloidosis Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Amyloidosis Therapeutics Import and Export
5.8 India Amyloidosis Therapeutics Market Analysis
5.8.1 India Amyloidosis Therapeutics Production
5.8.2 India Amyloidosis Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Amyloidosis Therapeutics Import and Export
6 Amyloidosis Therapeutics Segment Market Analysis (by Type)
6.1 Global Amyloidosis Therapeutics Production by Type
6.2 Global Amyloidosis Therapeutics Revenue by Type
6.3 Amyloidosis Therapeutics Price by Type
7 Amyloidosis Therapeutics Segment Market Analysis (by Application)
7.1 Global Amyloidosis Therapeutics Consumption by Application
7.2 Global Amyloidosis Therapeutics Consumption Market Share by Application (2014-2019)
8 Amyloidosis Therapeutics Major Manufacturers Analysis
8.1 Pfizer Inc.
8.1.1 Pfizer Inc. Amyloidosis Therapeutics Production Sites and Area Served
8.1.2 Pfizer Inc. Product Introduction, Application and Specification
8.1.3 Pfizer Inc. Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 ProteoTech, Inc.
8.2.1 ProteoTech, Inc. Amyloidosis Therapeutics Production Sites and Area Served
8.2.2 ProteoTech, Inc. Product Introduction, Application and Specification
8.2.3 ProteoTech, Inc. Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Alnylam Pharmaceuticals, Inc.
8.3.1 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
8.3.2 Alnylam Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.3.3 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Arcturus Therapeutics, Inc
8.4.1 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Production Sites and Area Served
8.4.2 Arcturus Therapeutics, Inc Product Introduction, Application and Specification
8.4.3 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bellus Health Inc.
8.5.1 Bellus Health Inc. Amyloidosis Therapeutics Production Sites and Area Served
8.5.2 Bellus Health Inc. Product Introduction, Application and Specification
8.5.3 Bellus Health Inc. Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bsim2
8.6.1 Bsim2 Amyloidosis Therapeutics Production Sites and Area Served
8.6.2 Bsim2 Product Introduction, Application and Specification
8.6.3 Bsim2 Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Celgene Corporation
8.7.1 Celgene Corporation Amyloidosis Therapeutics Production Sites and Area Served
8.7.2 Celgene Corporation Product Introduction, Application and Specification
8.7.3 Celgene Corporation Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Millennium Pharmaceuticals, Inc.
8.8.1 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
8.8.2 Millennium Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.8.3 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Onyx Pharmaceuticals, Inc.
8.9.1 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
8.9.2 Onyx Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.9.3 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 GlaxoSmithKline Plc
8.10.1 GlaxoSmithKline Plc Amyloidosis Therapeutics Production Sites and Area Served
8.10.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.10.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Isis Pharmaceuticals, Inc.
8.12 Prothena Corporation Plc
8.13 SOM Innovation Biotech SL
9 Development Trend of Analysis of Amyloidosis Therapeutics Market
9.1 Global Amyloidosis Therapeutics Market Trend Analysis
9.1.1 Global Amyloidosis Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Amyloidosis Therapeutics Regional Market Trend
9.2.1 North America Amyloidosis Therapeutics Forecast 2019-2025
9.2.2 Europe Amyloidosis Therapeutics Forecast 2019-2025
9.2.3 China Amyloidosis Therapeutics Forecast 2019-2025
9.2.4 Japan Amyloidosis Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Amyloidosis Therapeutics Forecast 2019-2025
9.2.6 India Amyloidosis Therapeutics Forecast 2019-2025
9.3 Amyloidosis Therapeutics Market Trend (Product Type)
9.4 Amyloidosis Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Amyloidosis Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Amyloidosis Therapeutics
Table Global Amyloidosis Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Amyloidosis Therapeutics Production Market Share by Types in 2018
Figure AG-10 Product Picture
Figure ALN-ANG Product Picture
Figure ALN-TTRsc02 Product Picture
Figure CAEL-101 Product Picture
Figure canakinumab Product Picture
Figure Others Product Picture
Table Global Amyloidosis Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Amyloidosis Therapeutics Consumption Market Share by Applications in 2018
Figure AL amyloidosis
Figure AA amyloidoses
Figure ATTR amyloidoses
Figure Others
Figure Global Amyloidosis Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Amyloidosis Therapeutics Production (K Pcs) (2014-2025)
Figure North America Amyloidosis Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Amyloidosis Therapeutics Market Size (Million USD) (2014-2025)
Figure China Amyloidosis Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Amyloidosis Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Amyloidosis Therapeutics Market Size (Million USD) (2014-2025)
Figure India Amyloidosis Therapeutics Market Size (Million USD) (2014-2025)
Table Amyloidosis Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Amyloidosis Therapeutics in 2018
Figure Manufacturing Process Analysis of Amyloidosis Therapeutics
Figure Industry Chain Structure of Amyloidosis Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Amyloidosis Therapeutics Manufacturing Plants Distribution
Table Amyloidosis Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Amyloidosis Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Amyloidosis Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Amyloidosis Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Amyloidosis Therapeutics Production Share by Manufacturers in 2018
Table Amyloidosis Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Amyloidosis Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Amyloidosis Therapeutics Revenue Share by Manufacturers in 2018
Table Amyloidosis Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Amyloidosis Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Amyloidosis Therapeutics Production Market Share by Regions 2014-2019
Figure Global Amyloidosis Therapeutics Production Market Share by Regions in 2018
Table Global Amyloidosis Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Amyloidosis Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Amyloidosis Therapeutics Revenue Market Share by Regions in 2018
Table Global Amyloidosis Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Amyloidosis Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Amyloidosis Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Amyloidosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Amyloidosis Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Amyloidosis Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Amyloidosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Amyloidosis Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Amyloidosis Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Amyloidosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Amyloidosis Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Amyloidosis Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Amyloidosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Amyloidosis Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Amyloidosis Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Amyloidosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Amyloidosis Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Amyloidosis Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Amyloidosis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Amyloidosis Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Amyloidosis Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Amyloidosis Therapeutics Market Share by Application (2014-2019)
Table Pfizer Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table Pfizer Inc. Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Pfizer Inc. Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Inc. Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Pfizer Inc. Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Pfizer Inc. Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Pfizer Inc. Amyloidosis Therapeutics Main Business and Markets Served
Table ProteoTech, Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table ProteoTech, Inc. Amyloidosis Therapeutics Product Introduction, Application and Specification
Table ProteoTech, Inc. Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ProteoTech, Inc. Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table ProteoTech, Inc. Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure ProteoTech, Inc. Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table ProteoTech, Inc. Amyloidosis Therapeutics Main Business and Markets Served
Table Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Main Business and Markets Served
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Production Sites and Area Served
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Arcturus Therapeutics, Inc Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Main Business and Markets Served
Table Bellus Health Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table Bellus Health Inc. Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Bellus Health Inc. Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bellus Health Inc. Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Bellus Health Inc. Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Bellus Health Inc. Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Bellus Health Inc. Amyloidosis Therapeutics Main Business and Markets Served
Table Bsim2 Amyloidosis Therapeutics Production Sites and Area Served
Table Bsim2 Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Bsim2 Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bsim2 Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Bsim2 Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Bsim2 Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Bsim2 Amyloidosis Therapeutics Main Business and Markets Served
Table Celgene Corporation Amyloidosis Therapeutics Production Sites and Area Served
Table Celgene Corporation Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Celgene Corporation Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corporation Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Celgene Corporation Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Celgene Corporation Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Celgene Corporation Amyloidosis Therapeutics Main Business and Markets Served
Table Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Main Business and Markets Served
Table Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Introduction, Application and Specification
Table Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Main Business and Markets Served
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Production Sites and Area Served
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Amyloidosis Therapeutics Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Main Business and Markets Served
Table Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Production Sites and Area Served
Table Prothena Corporation Plc Amyloidosis Therapeutics Production Sites and Area Served
Table SOM Innovation Biotech SL Amyloidosis Therapeutics Production Sites and Area Served
Figure Global Amyloidosis Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Amyloidosis Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Amyloidosis Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Amyloidosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Amyloidosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Amyloidosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Amyloidosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Amyloidosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Amyloidosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Amyloidosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Amyloidosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Amyloidosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Amyloidosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Amyloidosis Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Amyloidosis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Amyloidosis Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Amyloidosis Therapeutics by Application (2019-2025)
Table Amyloidosis Therapeutics Distributors List
Table Amyloidosis Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アテローム性動脈硬化症治療薬のグローバル市場：規模・現状・予測2019-2025 Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.The identification of new drug targets for atherosclerosis will be one of the critical atherosclerosis therapeutics market trends driving the growth of the market. Although statins are regarded as the…- アテローム性動脈硬化症治療薬のグローバル市場：規模・現状・予測2019-2025 Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.The identification of new drug targets for atherosclerosis will be one of the critical atherosclerosis therapeutics market trends driving the growth of the market. Although statins are regarded as the…
- 脾腫治療法のグローバル市場：規模・現状・予測2019-2025 Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of the four cardinal signs of hypersplenism which include: some reduction in number of circulating blood cells affecting granulocytes, erythrocytes or plate…
- 脾腫治療法のグローバル市場：規模・現状・予測2019-2025 Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of the four cardinal signs of hypersplenism which include: some reduction in number of circulating blood cells affecting granulocytes, erythrocytes or plate…
- 増殖性硝子体網膜症（PVR）治療法のグローバル市場調査 2019年 The global Proliferative Vitreoretinopathy (PVR) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proliferative Vitreoretinopathy (PVR) Therapeutics volume and value at global level, reg…